La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Medical Properties Trust a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Medical Properties Trust..

Medical Properties Trust (NYSE:MPW) Azioni, Catena delle Opzioni

MEDICAL PROPERTIES TRUST INC

Medical Properties Trust

Medical Properties Trust Inc acquires and develops net-leased healthcare facilities. Its investments in healthcare real estate, other loans, and any investments in tenants are considered a single reportable segment. The group's geographic areas are the United States, the United Kingdom, and All other countries.

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

TRNO

WELL

Analisi approfondita su tre titoli del settore immobiliare che mostrano segnali di rischio significativo nel primo trimestre.

Crollo imminente? 3 titoli immobiliari da evitare nel primo trimestre

Dividends

Price Target

Analyst Ratings

Scopri i 3 migliori titoli immobiliari con dividendi oltre il 7% consigliati da Wall Street per investimenti redditizi.

3 titoli immobiliari con dividendi superiori al 7% consigliati da Wall Street

Medical Properties Trust, Inc. common stock

Medical Properties Trust Inc

Monolithic Power Systems, Inc. - Common Stock

Monolithic Power Systems Inc

Medical Properties Trust's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) short percent of float has fallen 4.09% since its last report. The company recently reported that it has 176.85 million shares sold short, which is 40.8% of all regular shares that are available for trading. Based on its trading volume, it would take traders 13.38 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Medical Properties Trust Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743181226_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Medical Properties Trust has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Medical Properties Trust's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Medical Properties Trust's peer group average for short interest as a percentage of float is 4.65%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

What Does the Market Think About Medical Properties Trust?

Investing in dividend-paying stocks has long been a popular investment strategy for those seeking to generate <a href="https://www.benzinga.com/markets/25/03/44244110/how-this-59-year-old-investor-built-a-real-estate-portfolio-that-generates-105kper-month-in-passive">passive income</a> and build long-term wealth.
A well-constructed portfolio provides a cash flow stream and the potential for capital appreciation over time for the investor, so many are seeking advice online on this matter. For many individuals, <a href="https://www.benzinga.com/markets/25/01/43372321/im-39-and-built-900k-in-7-years-dividend-investor-eyes-retirement-by-55-with-explosive-income-shares">dividend</a> investments are charming because of their ability to compound returns, especially when reinvested. Yet, building a portfolio to reap these benefits requires discipline, patience, and a good strategy.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>
And this is what a Reddit user has done. The investor recently shared his success story in a community on the discussion board, revealing that he&#8217;s crossed the $12,895 per year in dividends milestone. This achievement, which took him nearly three years to accomplish, brings him an extra $1,000 per month in passive income.
&#8220;It took me almost three years to get to this point… I have the feeling it's gonna really start taking off from here! Pretty pumped!&#8221; the investor wrote.
The investor&#8217;s portfolio consists of over 18 stocks and funds, each contributing to the $12,895 annual dividend income. Let&#8217;s explore the poster&#8217;s top 10 favorite holdings below.
Trending: It&#8217;s no wonder Jeff Bezos holds over $250 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a>
<h2 class="wp-block-heading">$12,895/Year in Dividend Income: Top 10 Stocks and Funds That Contribute to This Sum</h2>
ZIM Integrated Shipping Services
Israeli shipping company ZIM Integrated Shipping Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) operates globally and has benefited from high freight rates. ZIM has an annual dividend yield of approximately 39.60%.
TORM Plc
Based in Denmark, TORM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRMD#NASDAQ">TRMD</a>) is a container shipping company that transports refined oil products. Investors like TRMD because of its high dividend history and exposure to global oil transport. The company pays 36.66% in dividends.
Mesabi Trust
With an annual dividend yield of 25.84%, Mesabi Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSB#NYSE">MSB</a>) is a royalty trust that makes revenue from iron ore production in Minnesota, with distributions based on the mining company's earnings. Individuals invest in MSB because of the exposure to commodities it offers and the high dividends it pays.
Medical Properties Trust
A real estate investment trust, Medical Properties Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) pays investors 5.48% annually in dividends. MPW owns hospitals and leases them to operators, and has a history of strong dividend paying.
VOC Energy Trust
VOC Energy Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOC#NYSE">VOC</a>) is a royalty trust earning revenue from oil and gas production in Texas and Kansas. VOC pays investors approximately 22.71% in annual dividends and is sought especially during high oil prices.
See Also: Have $200K saved?<a href="https://www.benzinga.com/money/have-200k-saved-heres-how-to-turn-it-into-lasting-wealth"> Here's how to turn it into lasting wealth</a>
Amplify High Income ETF
Paying 12.58% in dividends, Amplify High Income ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YYY#NYSE">YYY</a>) is an ETF focused on high-income closed-end funds, offering diversified high-yield exposure.
Abrdn Income Credit Strategies Fund
Another closed-end fund, Abrdn Income Credit Strategies Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACP#NYSE">ACP</a>) invests in high-yield bonds and credit securities. ACP pays investors approximately 18.73% in dividends.
Vale S.A.
Vale&nbsp; (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VALE#NYSE">VALE</a>) is a Brazilian mining giant focused on iron ore, nickel, and copper, and one of the largest iron ore producers globally. VALE has an annual dividend yield of around 7.76%.
Verizon Communications
With a dividend yield of around 6.21%, Verizon Communications (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>) is a major U.S. telecom company providing wireless and broadband services. Investors like VZ because of its stable, defensive stock with a long history of dividend growth.
Aker BP ASA
Aker BP ASA is a Norwegian oil and gas company focusing on offshore production in the North Sea. Paying investors approximately 12.1% in annual dividends, AKRBF has solid payouts and growth potential.&nbsp;
Read Next:
<ul>
<li>Dogecoin millionaires are increasing –<a href="https://www.benzinga.com/money/dogecoin-millionaires"> investors with $1M+ in DOGE revealed!</a></li>
<li>How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.</li>
</ul>

Personal Finance

TRMD

VALE

High-Yield Dividend Investor Making $12,900 Per Year Names 10 Favorite Stocks – 'Took Me Almost 3 Years To Get To This Point'

WIIM

Medical Properties Trust shares are trading higher after Exane BNP Paribas upgraded the stock from neutral to outperform and raised the price target from $5 to $9.

Medical Properties Trust shares are trading higher after Exane BNP Paribas upgraded the stock from neutral to outperform and raises the price target from $5 to $9.

Exane BNP Paribas analyst Nate Crossett upgrades Medical Properties Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) from Neutral to Outperform and raises the price target from $5 to $9.

Upgrades

Exane BNP Paribas Upgrades Medical Properties Trust to Outperform, Raises Price Target to $9

RBC Capital analyst Michael Carroll maintains Medical Properties Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) with a Sector Perform and raises the price target from $4 to $5.

RBC Capital Maintains Sector Perform on Medical Properties Trust, Raises Price Target to $5

Wells Fargo analyst Connor Siversky maintains Medical Properties Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) with a Underweight and raises the price target from $4 to $5.

Wells Fargo Maintains Underweight on Medical Properties Trust, Raises Price Target to $5

These eight mid-cap stocks were the best performers in the last week. Are they in your portfolio?
<ol>
<li>Root, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROOT#NASDAQ">ROOT</a>) stock gained 34.89% after the company reported <a href="https://www.benzinga.com//node/43993814" target="_blank" rel="noreferrer noopener">better-than-expected Q4</a> financial results. Wells Fargo raised the price forecast on the stock <a href="https://www.benzinga.com/quote/ROOT/analyst-ratings" target="_blank" rel="noreferrer noopener">from $80 to $97</a>.</li>
<li>Bridge Investment Group Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRDG#NYSE">BRDG</a>) shares jumped 32.45% after the company entered a deal to be acquired by Apollo Global Management, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) in an all-stock <a href="https://www.benzinga.com//node/43917364" target="_blank" rel="noreferrer noopener">transaction valued at around $1.5 billion</a>. Analysts revised the <a href="https://www.benzinga.com/quote/brdg/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecast on the stock</a>.</li>
<li>Huron Consulting Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HURN#NASDAQ">HURN</a>) shares rose 23.21% after the company reported better-than-<a href="https://www.benzinga.com//node/43956537" target="_blank" rel="noreferrer noopener">expected quarterly financial results</a>. Also, multiple firms raised their respective <a href="https://www.benzinga.com/quote/hurn/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecast on the stock</a>.</li>
<li>Medical Properties Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) shares increased 21.15% after the company reported better-<a href="https://www.benzinga.com//node/44004172" target="_blank" rel="noreferrer noopener">than-expected financial results</a>.</li>
<li>ZoomInfo Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZI#NASDAQ">ZI</a>) stock escalated 20.83% after the company reported 2024 <a href="https://www.benzinga.com//node/43990629" target="_blank" rel="noreferrer noopener">fiscal-year fourth-quarter earnings</a>. Scotiabank analyst Allan Verkhovski maintained a Sector Perform rating and raised the price <a href="https://www.benzinga.com/quote/zi/analyst-ratings" target="_blank" rel="noreferrer noopener">forecast from $10.3 to $11</a>.</li>
<li>Lantheus Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNTH#NASDAQ">LNTH</a>) stock rose 19.93% after it reported quarterly adjusted <a href="https://www.benzinga.com//node/43968835" target="_blank" rel="noreferrer noopener">EPS and sales above estimates</a>. Truist Securities analyst Richard Newitter maintained a Buy rating and raised the <a href="https://www.benzinga.com/quote/lnth/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecast from $120 to $127</a>.</li>
<li>Alignment Healthcare, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALHC#NASDAQ">ALHC</a>) stock gained 19.04% after the company reported better-than-expected Q4 financial results and issued an FY25 outlook. Multiple analyst firms raised their respective <a href="https://www.benzinga.com/quote/ALHC/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecasts on the stock</a>.</li>
<li>VSE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSEC#NASDAQ">VSEC</a>) stock jumped 18.49%  after the company reported better-than-<a href="https://www.benzinga.com//node/43990909" target="_blank" rel="noreferrer noopener">expected fourth-quarter results</a>.</li>
</ol>
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/44067124/xpeng-li-auto-and-anheuser-busch-inbev-are-among-top-11-large-cap-gainers-last-week-feb-24-feb-28-are-the-others-in-your-portfolio" target="_blank" rel="noreferrer noopener">Xpeng, Li Auto And Nutanix Are Among Top 12 Large-Cap Gainers Last Week (Feb 24-Feb 28): Are The Others In Your Portfolio?</a></li>
<li><a href="https://www.benzinga.com/news/large-cap/25/03/44067248/tesla-palantir-and-microstrategy-are-among-top-12-large-cap-losers-last-week-feb-24-feb-28-are-the-others-in-your-portfolio" target="_blank" rel="noreferrer noopener">Tesla, Palantir And MicroStrategy Are Among Top 12 Large-Cap Losers Last Week (Feb 24-Feb 28): Are The Others In Your Portfolio?</a></li>
</ul>

Equities

Mid Cap

Movers

ALHC

BRDG

HURN

LNTH

ROOT

VSEC

Root And ZoomInfo Are Among Top 8 Mid-Cap Gainers Last Week (Feb 24-Feb 28): Are The Others In Your Portfolio?

Medical Properties Trust shares are trading higher after the company reported better-than-expected Q4 financial results.

Medical Properties Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.16 by 12.5 percent. This is a 50 percent decrease over earnings of $0.36 per share from the same period last year. The company reported quarterly sales of $231.84 million which beat the analyst consensus estimate of $217.57 million by 6.56 percent. This is a 31.13 percent decrease over sales of $336.62 million the same period last year.

Earnings

Medical Properties Trust Q4 FFO $0.18 Beats $0.16 Estimate, Sales $231.84M Beat $217.57M Estimate

AAON

ABCL

ACEL

ACHC

ACHR

ACIC

ACIW

ADSK

AIRG

ALEX

ALKT

ALTM

AMBP

AMPH

AMRC

AMWD

ARGX

ARLO

ARRY

ASTH

AUPH

AVPT

BBWI

BCSF

BECN

BLND

BWMX

CABO

CARS

CCOI

CDXS

CLCO

CLOV

CMBT

CMLS

CMPS

CODI

COLL

CRDF

CRNX

CRON

CSTL

CTKB

CUBE

CVEO

CYTK

DAIO

DCGO

DELL

DUOL

ECVT

EFXT

ERIE

Embraer-Empresa Brasileira De Aeronautica

ESEA

ESTC

EVRG

EXFY

FIGS

FOXF

FTDR

FWONA

FWONK

GBTG

GDEN

GDOT

GDRX

Earnings Scheduled For February 27, 2025

Reported Earlier, Medical Properties Trust Prices $1.5B 8.500% Senior Secured Notes And €1B 7.000% Senior Secured Notes, Both Maturing In 2032

Medical Properties Trust, Inc. (the "Company" or "MPT") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) today announced that its operating partnership, MPT Operating Partnership, L.P. and MPT Finance Corporation, a wholly-owned subsidiary of the operating partnership (together, the "Issuers") have commenced a private offering of up to $2.0 billion in aggregate principal amount of its senior secured notes due 2032 and €500 million aggregate principal amount of its senior secured notes due 2032 (together, the "Notes"). The Issuers intend to use a portion of the net proceeds of the Notes to fund the redemption in full of the Issuers' 3.325% senior notes due 2025, 2.500% senior notes due 2026 and 5.250% senior notes due 2026, including related accrued interest, fees and expenses. The Issuers intend to use any remaining net proceeds for general corporate purposes, which may include repaying other indebtedness, including amounts outstanding from time-to-time under the Company's revolving credit facility, working capital, capital expenditures and potential future acquisitions.

Offerings

Medical Properties Trust Has Commenced A Private Offering Of Up To $2B In Aggregate Principal Amount Of Its Senior Secured Notes Due 2032 And €500 Million Aggregate Principal Amount Of Its Senior Secured Notes Due 2032

As of Jan. 27, 2025, three stocks in the real estate sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Terreno Realty Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRNO#NYSE">TRNO</a>)</h3>
<ul>
<li>On Jan. 17, Terreno Realty sold an industrial property located in South San Francisco, California on January 16, 2025 for a sale price of approximately $8.0 million. The company's stock surged around 10% over the past month and has a <a href="https://www.benzinga.com/quote/TRNO">52-week high of $71.63</a>.</li>
<li>RSI Value: 74&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>TRNO Price Action: Shares of Terreno Realty gained 0.5% to close at $64.99 on Friday.</li>
</ul>
<h3 class="wp-block-heading">Welltower Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WELL#NYSE">WELL</a>)</h3>
<ul>
<li>On Jan. 24, B of A Securities maintained a Buy rating on the stock and raised its price target from $190 to $221. The company's stock gained around 9% over the past month and <a href="https://www.benzinga.com/quote/WELL">has a 52-week high</a> of $140.75.</li>
<li>RSI Value: 72.9</li>
<li>WELL Price Action: Shares of Welltower gained 3.4% to close at $136.75 on Friday.</li>
</ul>
<h3 class="wp-block-heading">Medical Properties Trust Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>)</h3>
<ul>
<li>On Dec. 19, 2024, Truist Securities analyst Michael Lewis maintained Medical Properties Trust with a Hold and lowered the price target from $6 to $4. The company's stock gained around 26% over the past month and has a <a href="https://www.benzinga.com/quote/MPW">52-week high</a> of $6.55.</li>
<li>RSI Value: 71.2</li>
<li>MPW Price Action: Shares of Medical Properties Trust gained 2.6% to close at $4.69 on Friday.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43221604/att-nucor-and-3-stocks-to-watch-heading-into-monday">AT&amp;T, Nucor And 3 Stocks To Watch Heading Into Monday</a></li>
</ul>

Top 3 Real Estate Stocks That May Plunge In Q1

Reported Earlier, Medical Properties Trust Supports Prospect's Chapter 11 Sale Plans For Connecticut Hospitals

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the real estate sector.
<h3 class="wp-block-heading">Medical Properties Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>)</h3>
<ul>
<li>Dividend Yield: 8.54%</li>
<li>Truist Securities analyst Michael Lewis maintained a Hold rating and cut the price target from $6 to $4 on Dec. 19, 2024. This analyst has an accuracy rate of 69%.</li>
<li>RBC Capital analyst Michael Carroll downgraded the stock from Outperform to Sector Perform with a price target of $5 on May 14, 2024. This analyst has an accuracy rate of 61%.</li>
<li>Recent News: On Nov.7, Medical Properties Trust reported worse-than-expected third-quarter financial results.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011025&amp;t=be2bearmibe3na1">latest MPW news.</a> </li>
</ul>
<figure class="wp-block-image is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011025&amp;t=be2bearmibe3na1"><img decoding="async" src="blob:https://editorial.benzinga.com/8356f98b-748a-4a66-8e7b-6e4f0dc6db31" alt="" style="width:606px;height:auto" /></a></figure>
<h3 class="wp-block-heading">EPR Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPR#NYSE">EPR</a>)</h3>
<ul>
<li>Dividend Yield: 7.74%</li>
<li>JP Morgan analyst Anthony Paolone maintained an Overweight rating and raised the price target from $48 to $51 on Sept. 9, 2024. This analyst has an accuracy rate of 64%.</li>
<li>Truist Securities analyst Ki Bin Kim maintained a Hold rating and boosted the price target from $44 to $46 on Aug. 16, 2024. This analyst has an accuracy rate of 67%.</li>
<li>Recent News: On Oct. 30, EPR Props posted better-than-expected quarterly results.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011025&amp;t=be2bearmibe3na1">latest EPR new</a>s.</li>
</ul>
<figure class="wp-block-image is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011025&amp;t=be2bearmibe3na1"><img decoding="async" src="blob:https://editorial.benzinga.com/25fde8ab-3a45-4b71-980a-0efe0c0d9950" alt="" style="width:631px;height:auto" /></a></figure>
<h3 class="wp-block-heading">Omega Healthcare Investors, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OHI#NYSE">OHI</a>)</h3>
<ul>
<li>Dividend Yield: 7.39%</li>
<li>RBC Capital analyst Michael Carroll maintained a Sector Perform rating and raised the price target from $39 to $43 on Nov. 11, 2024. This analyst has an accuracy rate of 61%.</li>
<li>Wells Fargo analyst Connor Siversky assumed an Overweight rating and increased the price target from $40 to $43 on Oct. 1, 2024. This analyst has an accuracy rate of 63%.</li>
<li>Recent News: On Jan. 6, Omega Healthcare Investors named Matthew Gourmand as President.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011025&amp;t=be2bearmibe3na1">OHI news</a>.</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011025&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="893" height="827" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10133010/image-64.png" alt="" class="wp-image-728777" style="width:563px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10133010/image-64.png 893w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10133010/image-64-300x278.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10133010/image-64-768x711.png 768w" sizes="(max-width: 893px) 100vw, 893px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42917071/top-2-health-care-stocks-that-are-ticking-portfolio-bombs-2">Top 2 Health Care Stocks That Are Ticking Portfolio Bombs</a></li>
</ul>

Wall Street's Most Accurate Analysts Weigh In On 3 Real Estate Stocks With Over 7% Dividend Yields

Truist Securities analyst Michael Lewis maintains Medical Properties Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) with a Hold and lowers the price target from $6 to $4.

Truist Securities Maintains Hold on Medical Properties Trust, Lowers Price Target to $4

Legal

Medical Properties Trust Reaches Agreement With Viceroy Research And Its Members To Mutually Settle And Dismiss Defamation Lawsuit Filed In 2023; Terms Confidential

Mizuho analyst Vikram Malhotra maintains Medical Properties Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) with a Neutral and lowers the price target from $6 to $5.

Mizuho Maintains Neutral on Medical Properties Trust, Lowers Price Target to $5

Investors with a lot of money to spend have taken a bearish stance on Medical Properties Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with MPW, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 16 uncommon options trades for Medical Properties Trust.
This isn't normal.
The overall sentiment of these big-money traders is split between 6% bullish and 75%, bearish.
Out of all of the special options we uncovered, 11 are puts, for a total amount of $1,537,381, and 5 are calls, for a total amount of $204,471.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $0.5 to $7.0 for Medical Properties Trust over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Medical Properties Trust's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Medical Properties Trust's substantial trades, within a strike price spectrum from $0.5 to $7.0 over the preceding 30 days.
<h3>Medical Properties Trust Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732044642_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MPW</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$3.2</td>
<td>$3.15</td>
<td>$3.2</td>
<td>$7.00</td>
<td>$320.0K</td>
<td>4.3K</td>
<td>1.4K</td>
</tr>
<tr>
<td>MPW</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$1.59</td>
<td>$1.34</td>
<td>$1.45</td>
<td>$5.50</td>
<td>$290.0K</td>
<td>13.5K</td>
<td>2.3K</td>
</tr>
<tr>
<td>MPW</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$3.2</td>
<td>$3.15</td>
<td>$3.2</td>
<td>$7.00</td>
<td>$224.9K</td>
<td>4.3K</td>
<td>5.9K</td>
</tr>
<tr>
<td>MPW</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$3.2</td>
<td>$3.15</td>
<td>$3.2</td>
<td>$7.00</td>
<td>$160.0K</td>
<td>4.3K</td>
<td>4.8K</td>
</tr>
<tr>
<td>MPW</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$3.2</td>
<td>$3.15</td>
<td>$3.2</td>
<td>$7.00</td>
<td>$160.0K</td>
<td>4.3K</td>
<td>4.3K</td>
</tr>
</tbody>
</table>

<h3>About Medical Properties Trust</h3>
Medical Properties Trust Inc is a healthcare facility REIT. The company operates one segment, which owns and leases healthcare facilities. The vast majority of Medical's revenue is generated in the United States, followed by Germany and the United Kingdom. It provides financing for a variety of facilities that require funds for acquisitions, sale-leasebacks, new developments, and expansion projects.
Having examined the options trading patterns of Medical Properties Trust, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Medical Properties Trust</h3>
<ul>
<li>With a trading volume of 6,182,287, the price of MPW is up by 1.43%, reaching $4.27.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 92 days from now.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Medical Properties Trust options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Medical Properties Trust Unusual Options Activity For November 19

Press Releases

Medical Properties Trust, Inc. Reports Third Quarter Results

Medical Properties Trust Announces Prospect's Binding Agreement to Sell Managed Care Business to Astrana Health

Medical Properties Trust Declares Regular Quarterly Dividend

Medical Properties Trust Announces Settlement with Viceroy Research

Medical Properties Trust Comments on Prospect Restructuring

Medical Properties Trust Announces Private Offering of Senior Secured Notes

Medical Properties Trust Announces Pricing of $1.5 Billion 8.500% Senior Secured Notes Due 2032 and €1.0 Billion 7.000% Senior Secured Notes Due 2032

Medical Properties Trust, Inc. Announces Fourth Quarter 2024 Financial Results Conference Call and Webcast

Comments

Medical Properties Trust

Medical Properties Trust (MPW) Opzioni

Medical Properties Trust (NYSE:MPW) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO